Testing effectiveness (Phase 2)Ended earlyNCT00983047
What this trial is testing
Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer
Who this might be right for
Advanced Non-Small Cell Lung Cancer
Biotech Pharmaceutical Co., Ltd. 30